Protocol for the Determination of Menstrual Losses in Healthy Women With Apparently Normal Cycles (MEVA-1)
|ClinicalTrials.gov Identifier: NCT01276964|
Recruitment Status : Unknown
Verified July 2012 by Guglielmo Mariani, University of L'Aquila.
Recruitment status was: Recruiting
First Posted : January 14, 2011
Last Update Posted : July 16, 2012
|Condition or disease|
|Validate QUEM Method Quantitative Determination of Menses|
The following is a multicenter, observational, cross-over study intended to apply an easy and simple system for the quantitative determination of menstrual losses in women with apparently normal menses. The problem of heavy periods is associated to an high social and physical morbidity rate; till now there are not routine methods available for the quantitative determination of menstrual discharge, some objective methods have been applied exclusively for research purposes because they are very difficult to perform. If we consider the scientific data available and the frequent application of inadequate procedures for the treatment of this problem, it seems essential to apply a practical system for the accurate quantitative determination of menses.
The system adopted for the determination of menstrual losses, called QUEM (QUantitative Evaluation of Menses), is based on the collection of tampons and pads in standard bags which are readily vacuum sealed with a simple device for the whole of woman's period. QUEM has already been validated in preliminary in vitro and ex vivo studies (both in healthy women and in women with CBDs), by comparing it with the gold standard, the Alkaline Haematin Method. A correlation coefficient close to 1 was obtained.
In the current study QUEM will be applied to at least 100 women in the fertile age (between 20 and 45 years) with apparently normal menses and a negative bleeding history. The evaluation will be performed for the whole of one period and the analysis will be performed in comparison to the classical reference method, the Alkaline - Hematin Method, which is still considered the golden standard. At the enrollment each woman will be tested for complete blood cells count and ferritin levels in order to exclude unknown menorrhagia. The bleeding history (bleeding score) will be performed by applying an international reference method, already validated for von Willebrand Disease type 1 (vWD1). The aim of the study is to make a "normal range" and validate the effective practicality of QUEM as a preliminary step to the clinical studies in patients suffering from menorrhagia and affected by hemorrhagic disorders.
The current study will involve many Italian and International Centers. All the needed materials and equipments will be provided by the Coordinator Centre; patients will be carefully informed about the objectives of the study and they will follow a short course illustrating the use and the characteristics of the method proposed (QUEM).
|Study Type :||Observational|
|Estimated Enrollment :||150 participants|
|Official Title:||Protocol for the Determination of Menstrual Losses Using a System for the Quantitative Determination of Menses (Quantitative Evaluation of Menses [QUEM] Method) and Its Application to Healthy Women With Apparently Normal Cycles|
|Study Start Date :||September 2007|
|Estimated Primary Completion Date :||September 2012|
|Estimated Study Completion Date :||September 2012|
1. Women in the fertile age
Healthy women in the fertile age (between 20-45 years) with apparently normal periods
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01276964
|Contact: guglielmo mariani, email@example.com|
|Contact: mariasanta napolitano, firstname.lastname@example.org|
|University of L'Aquila||Recruiting|
|L'aquila, Italy, 67100|
|Contact: napolitano email@example.com|
|Principal Investigator: napolitano mariasanta, md|
|University of Palermo||Active, not recruiting|
|Palermo, Italy, 90127|
|Casa Sollievo Della Sofferenza Irccs||Recruiting|
|San Giovanni Rotondo, Italy, 71013|
|Contact: grandone firstname.lastname@example.org|
|Principal Investigator: elvira grandone, md|
|Principal Investigator:||mariasanta napolitano, md||univeristy of perugia, hospital of l'aquila|
|Study Director:||guglielmo mariani, md||University of L'Aquila|